Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ICU

SeaStar Medical Holding Corp

May 10 • 04:00PM ET

0.4030

Dollar change -0.0279
Percentage change -6.47	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.23	Insider Own	20.84%	Shs Outstand	75.42M	Perf Week	-10.16%
Market Cap	30.39M	Forward P/E	-	EPS next Y	-	Insider Trans	0.64%	Shs Float	59.71M	Perf Month	-43.95%
Income	-26.23M	PEG	-	EPS next Q	-	Inst Own	1.12%	Short Float	3.85%	Perf Quarter	-53.13%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-0.13%	Short Ratio	0.45	Perf Half Y	-39.85%
Book/sh	-0.29	P/B	-	EPS next Y	-	ROA	-633.62%	Short Interest	2.30M	Perf Year	-65.56%
Cash/sh	0.00	P/C	168.86	EPS next 5Y	-	ROE	-103.15%	52W Range	0.16 - 1.72	Perf YTD	-8.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-76.53%	Beta	-0.95
Dividend TTM	-	Quick Ratio	0.18	Sales past 5Y	0.00%	Gross Margin	-	52W Low	148.77%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	0.18	EPS Y/Y TTM	32.49%	Oper. Margin	0.00%	RSI (14)	36.47	Volatility	10.27% 14.79%
Employees	12	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	2.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	89.85%	Payout	-	Rel Volume	0.52	Prev Close	0.43
Sales Surprise	-	EPS Surprise	-46.15%	Sales Q/Q	-	Earnings	Apr 18 BMO	Avg Volume	5.14M	Price	0.40
SMA20	-21.59%	SMA50	-39.85%	SMA200	-30.54%	Trades		Volume	2,655,245	Change	-6.47%

Apr-30-24 08:30AM	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure (GlobeNewswire) -6.61%
Apr-17-24 04:00PM	SeaStar Medical Reports 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Apr-16-24 11:52PM	ICU Stock Earnings: SeaStar Medical Holding Misses EPS for Q4 2023 (InvestorPlace) +7.20%
Apr-11-24 08:30AM	SeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity Conference (GlobeNewswire)
Apr-02-24 11:26AM	LM Funding America, Inc. (NASDAQ:LMFA) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.95%
08:30AM	Loading…
Mar-27-24 08:30AM	SeaStar Medical to Restate Financials, Sets Business Update Call for April 17 (GlobeNewswire)
Mar-12-24 08:30AM	SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients (GlobeNewswire) +11.00%
Mar-11-24 04:05PM	SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024 (GlobeNewswire) +11.64%
Feb-27-24 08:30AM	Manuscript Discussing the Benefit of SeaStar Medical's Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure (GlobeNewswire) -7.85%
Feb-22-24 07:58AM	Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune (GlobeNewswire) -23.45%
07:53AM	FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney Injury (GlobeNewswire)
Feb-01-24 08:30AM	SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology (GlobeNewswire)
Jan-26-24 08:05AM	SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) -5.59%
Jan-11-24 04:05PM	SeaStar Medical Appoints David A. Green as Chief Financial Officer (GlobeNewswire) -8.41%
Jan-09-24 08:30AM	SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications (GlobeNewswire)
08:30AM	Loading…
Dec-28-23 08:30AM	SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire) -5.93%
Dec-13-23 08:30AM	SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts (GlobeNewswire)
Nov-14-23 04:04PM	SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Oct-31-23 08:00AM	Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device (GlobeNewswire) -17.93%
Oct-30-23 09:00PM	Discover the Next Nokia: 3 Penny Stocks With Big Potential (InvestorPlace)
08:00AM	FDA Issues Approvable Letter for SeaStar Medical's Selective Cytopheretic Device for Pediatric Patients (GlobeNewswire)
Oct-18-23 08:30AM	FDA Grants SeaStar Medical's Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome (GlobeNewswire) +70.05%
Oct-05-23 08:30AM	SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023 (GlobeNewswire)
Oct-03-23 04:05PM	SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption (GlobeNewswire) +41.49%
Oct-02-23 07:08PM	3 Micro-Cap Stocks Set to Explode Higher (InvestorPlace) +57.95%
Sep-29-23 08:30AM	FDA Grants Breakthrough Device Designation to SeaStar Medical's Selective Cytopheretic Device for Cardiorenal Syndrome (GlobeNewswire) +41.18%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire) -10.58%
Aug-29-23 08:00AM	Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medicals Selective Cytopheretic Device Published in the Journal Blood Purification (GlobeNewswire)
Aug-22-23 08:00AM	SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time (GlobeNewswire) +5.23%
Aug-14-23 04:35PM	SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
08:00AM	Loading…
Jun-30-23 08:00AM	SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients (GlobeNewswire)
Jun-20-23 04:05PM	First Patient Enrolled in SeaStar Medicals Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire)
Jun-14-23 08:00AM	SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023 (GlobeNewswire)
May-15-23 04:45PM	SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire) +8.52%
May-10-23 08:00AM	SeaStar Medical to Present at the JMP Securities Life Sciences Conference on May 16, 2023 (GlobeNewswire) -39.69%
May-09-23 04:05PM	SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device (GlobeNewswire)
Apr-19-23 08:00AM	SeaStar Medical Announces Activation of First Clinical Site in Pivotal Trial with Selective Cytopheretic Device in Critically Ill Adults with Acute Kidney Injury (GlobeNewswire)
Mar-30-23 07:23PM	SeaStar Medical Reports 2022 Financial Results and Provides a Business Update (GlobeNewswire)
Mar-21-23 07:00AM	Presenting on the Emerging Growth Conference on March 22 Register Now (GlobeNewswire)
Mar-16-23 08:00AM	SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement (GlobeNewswire) -9.72%
Mar-15-23 04:05PM	SeaStar Medical to Present at the Emerging Growth Virtual Conference on March 22, 2023 (GlobeNewswire) -7.30%
Feb-24-23 08:05AM	SeaStar Medicals Selective Cytopheretic Device to be Featured at the 5th Chronic Kidney Disease Drug Development Summit (GlobeNewswire)
Feb-15-23 04:01PM	SeaStar Medical Announces Details of the Selective Cytopheretic Device Pivotal Study in Critically ill Adults with Acute Kidney Injury (GlobeNewswire) +5.81%
Feb-14-23 04:05PM	SeaStar Medical to Hold Business Update Conference Call on February 15, 2023 (GlobeNewswire)
Feb-09-23 08:19AM	SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury (GlobeNewswire) -15.21%
Jan-31-23 08:00AM	SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023 (GlobeNewswire)
Jan-09-23 08:25AM	SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients (GlobeNewswire) +8.78%
Dec-29-22 01:35PM	SeaStar Medical and Nuwellis Enter into a U.S. License and Distribution Agreement for SeaStar Medicals Selective Cytopheretic Device (SCD) for Pediatric Acute Kidney Injury (AKI) (GlobeNewswire) +9.92%
09:02AM	SeaStar Medical, Nuwellis Ink US Licensing Pact For Acute Kidney Injury Device For Pediatric Patients (Benzinga)
Dec-02-22 09:05AM	SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development (GlobeNewswire)
Nov-29-22 09:05AM	SeaStar Medical Appoints Rick Barnett as Chairman of the Board of Directors (GlobeNewswire) -9.46%
Nov-17-22 08:27AM	SeaStar Medical Holding Corporation's (NASDAQ:ICU) top owners are individual investors with 51% stake, while49% is held by institutions (Simply Wall St.) -12.68%
Nov-07-22 12:30PM	SeaStar Medicals Lead Product Candidate, the Selective Cytopheretic Device (SCD), Included in Consensus Statement for Pediatric Acute Kidney Injury in First Pediatric Acute Disease Quality Initiative (ADQI) Meeting (GlobeNewswire) -10.11%
Nov-03-22 09:00AM	SeaStar Medical (Nasdaq: ICU) Announces Positive Interim Safety Findings from Ongoing Study Evaluating the Selective Cytopheretic Device (SCD) in Children (GlobeNewswire) -7.35%
Oct-31-22 09:25AM	SeaStar Medical (NASDAQ: ICU) Commences Trading on Nasdaq Capital Market and Outlines Corporate Strategy and Near-Term Catalysts (GlobeNewswire) -11.90%

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Heel Kenneth	Director	Nov 22 '23	Buy	0.40	100,000	40,000	116,400	Nov 27 04:05 PM
Chung Kevin	Chief Medical Officer	May 30 '23	Buy	0.47	12,543	5,953	68,125	Jun 01 04:01 PM
Russell Richard D.	Director	May 25 '23	Buy	0.50	20,000	10,000	27,978	May 30 04:01 PM
Chung Kevin	Chief Medical Officer	May 18 '23	Buy	0.70	7,500	5,248	55,582	May 22 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICU

SeaStar Medical Holding Corp

Upgrade your FINVIZ experience